Home
>
National Drug Code (NDC)
>
Tamoxifen Citrate
Tamoxifen Citrate - 0378-0274-01 - (Tamoxifen Citrate)
Drug Information of Tamoxifen Citrate
| Product NDC: | 0378-0274 |
| Proprietary Name: | Tamoxifen Citrate |
| Non Proprietary Name: | Tamoxifen Citrate |
| Active Ingredient(s): | 20 mg/1 & nbsp; Tamoxifen Citrate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Tamoxifen Citrate
| Product NDC: | 0378-0274 |
| Labeler Name: | Mylan Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074732 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130509 |
Package Information of Tamoxifen Citrate
| Package NDC: | 0378-0274-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (0378-0274-01) |
NDC Information of Tamoxifen Citrate
| NDC Code | 0378-0274-01 |
| Proprietary Name | Tamoxifen Citrate |
| Package Description | 100 TABLET in 1 BOTTLE (0378-0274-01) |
| Product NDC | 0378-0274 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Tamoxifen Citrate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20130509 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | TAMOXIFEN CITRATE |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA] |
